Eesti - eesti - Ravimiamet

ceva sante animale - prasikvanteel+püranteel - närimistablett - 20mg+80mg 4tk; 20mg+80mg 104tk; 20mg+80mg 50tk; 20mg+80mg 8tk; 20mg+80mg 24tk

Eesti - eesti - Ravimiamet

merck serono sia - progesteroon - vaginaalgeel - 90mg 1.125g 6tk; 90mg 1.125g 15tk

Eesti - eesti - Ravimiamet

desitin arzneimittel gmbh - diasepaam - rektaallahus - 5mg 2.5ml 2.5ml 5tk

Eesti - eesti - Ravimiamet

karo pharma ab - fluokortoloon+lidokaiin - rektaalsuposiit - 1mg+40mg 10tk; 1mg+40mg 3tk; 1mg+40mg 120tk

Eesti - eesti - Ravimiamet

glaxosmithkline dungarvan limited - nikotiin - transdermaalne plaaster - 21mg 24h 7tk; 21mg 24h 28tk

Eesti - eesti - Ravimiamet

glaxosmithkline dungarvan limited - nikotiin - transdermaalne plaaster - 7mg 24h 28tk

Eesti - eesti - Ravimiamet

glaxosmithkline dungarvan limited - nikotiin - transdermaalne plaaster - 14mg 24h 28tk; 14mg 24h 7tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastilised ained - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

Euroopa Liit - eesti - EMA (European Medicines Agency)

n.v. organon - colecalciferol, alendronic acid (as sodium trihydrate) - osteoporoos, postmenopausis - narkootikumid luuhaiguste raviks - menopausijärgse osteoporoosi ravi d-vitamiini puudulikkusega patsientidel. adrovance vähendab lülisamba ja puusaluu murrud.

Euroopa Liit - eesti - EMA (European Medicines Agency)

glaxo group ltd - retapamuliin - impetigo; staphylococcal skin infections - antibiootikumid ja kemoterapeutikumid dermatoloogiliseks kasutamiseks - short term treatment of the following superficial skin infections: , impetigo;, infected small lacerations, abrasions or sutured wounds. vt punkte 4. 4 ja 5. 1 oluline teave kliinilise tegevuse retapamulin vastu erinevad liigid staphylococcus aureus. tuleks arvesse võtta ametlikke juhiseid sobiva kasutada antibakteriaalseid aineid.